<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04698317</url>
  </required_header>
  <id_info>
    <org_study_id>≤ ≥ ° ± µ ™ ®</org_study_id>
    <nct_id>NCT04698317</nct_id>
  </id_info>
  <brief_title>Beta-Tricalcium Phosphate and Concentrated Growth Factors in Treatment of Intra-bony Defect Randomized Clinical Trial</brief_title>
  <acronym>RCT</acronym>
  <official_title>Biodegradable Gelatin Sponge Loaded With Beta-Tricalcium Phosphate Sponges Incorporating Concentrated Growth Factors in the Treatment of Intra-bony Pocket Randomized Clinical and Radiographic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical study aimed to evaluate the efficacy of biodegradable gelatin sponge loaded&#xD;
      with Beta-tricalcium phosphate socked in concentrated growth factors in the treatment of&#xD;
      periodontal intra-bony defects, as compared with biodegradable gelatin/beta-tricalcium&#xD;
      phosphate sponges alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      40 intra-bony defects in 40 patients will be selected from outpatient clinic of Oral&#xD;
      Periodontology Clinic Faculty of Dentistry, Tanta University to participate in this study.&#xD;
      Each defect had intra-bony depth &gt; or = 4 mm and probing pocket depth (PPD) &gt; or = 6 mm.&#xD;
      Patients will be randomly assigned to either test or control group. 20 patients will be&#xD;
      treated by surgery plus biodegradable gelatin/beta-tricalcium phosphate sponges alone.&#xD;
&#xD;
      (control group), the other 20 patients will be treated with the same surgical technique plus&#xD;
      biodegradable gelatin sponge loaded with Beta-tricalcium phosphate socked in concentrated&#xD;
      growth factors (test group).&#xD;
&#xD;
      Gingival index (GI), bleeding on probing, Probing pocket depth and clinical attachment level&#xD;
      (CAL) will assessed at baseline, 3, and 6 months at the site to be treated. Cone beam&#xD;
      radiographs evaluation will be taken at baseline, and 6 months after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Actual">July 1, 2021</completion_date>
  <primary_completion_date type="Actual">July 1, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>40 Patients will be randomly assigned to either test or control group. 20 patients will be treated by surgery plus biodegradable gelatin/beta-tricalcium phosphate sponges alone.&#xD;
(control group), the other 20 patients will be treated with the same surgical technique plus biodegradable gelatin sponge loaded with Beta-tricalcium phosphate socked in concentrated growth factors (test group).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>gingival index</measure>
    <time_frame>6months</time_frame>
    <description>gingival index will be recorded at baseline, 3, and 6 months at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>bleeding on probing</measure>
    <time_frame>6 months</time_frame>
    <description>bleeding on probing will be recorded at baseline, 3, and 6 months at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>probing pocket depth</measure>
    <time_frame>6 months</time_frame>
    <description>probing pocket depth will be recorded at baseline, 3, and 6 months at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical attachment level</measure>
    <time_frame>6 months</time_frame>
    <description>clinical attachment level will be recorded at baseline, 3, and 6 months at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cone beam x ray measuring defect area</measure>
    <time_frame>6 months</time_frame>
    <description>defect area will be recorded at baseline, and 6 months at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cone beam x ray measuring bone density</measure>
    <time_frame>6 months</time_frame>
    <description>bone density will be recorded at baseline, and 6 months at the site to be treated</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Chronic Periodontitis</condition>
  <condition>Intrabony Periodontal Defect</condition>
  <condition>Concentrated Growth Factors</condition>
  <arm_group>
    <arm_group_label>beta-tricalcium phosphate plus concentrated growth factors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>surgery plus biodegradable gelatin sponge loaded with Beta-tricalcium phosphate socked in concentrated growth factors (test group).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>beta tricalcium phosphate alone(control group)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>surgery plus biodegradable gelatin/beta-tricalcium phosphate sponges alone. (control group),</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open flap debridement</intervention_name>
    <description>Open flap for removal of diseased periodontal tissues and necrotic cementum</description>
    <arm_group_label>beta tricalcium phosphate alone(control group)</arm_group_label>
    <arm_group_label>beta-tricalcium phosphate plus concentrated growth factors</arm_group_label>
    <other_name>periodontal surgery</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>use of Biodegradable Gelatin Sponge loaded with Beta-tricalcium Phosphate plus concentrated growth factors</intervention_name>
    <description>use of Biodegradable Gelatin Sponge loaded with Beta-tricalcium Phosphate incorporating Concentrated Growth Factors in Periodontal Defect</description>
    <arm_group_label>beta-tricalcium phosphate plus concentrated growth factors</arm_group_label>
    <other_name>regenerative surgery</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>use of Biodegradable Gelatin Sponge loaded with Beta-tricalcium Phosphate alone</intervention_name>
    <description>use of Biodegradable Gelatin Sponge loaded with Beta-tricalcium Phosphate alone in the Intrabony Periodontal Defect</description>
    <arm_group_label>beta tricalcium phosphate alone(control group)</arm_group_label>
    <other_name>Regenerative surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  systemically healthy patients were selected&#xD;
&#xD;
          -  patients who had not received any medications for the previous six months that may&#xD;
             interfere with periodontal tissue health or healing.&#xD;
&#xD;
          -  Patients should demonstrate their ability to maintain good oral hygiene&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers and pregnant patients.&#xD;
&#xD;
          -  Medically compromised patients and systemic conditions precluding periodontal surgery.&#xD;
&#xD;
          -  Subjects who do not comply with oral hygiene measures as evidenced in recall visits.&#xD;
&#xD;
          -  Sites with tooth mobility&#xD;
&#xD;
          -  Restoration or caries in the site to be treated or non-vital tooth&#xD;
&#xD;
          -  Restoration or caries in the site to be treated or non-vital tooth&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>malak m shoukheba</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Malak Mohamed Shoukheba</name>
      <address>
        <city>Tanta</city>
        <zip>020</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 31, 2020</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>malak mohamed shoukheba</investigator_full_name>
    <investigator_title>associate prof.</investigator_title>
  </responsible_party>
  <keyword>Beta-Tricalcium Phosphate</keyword>
  <keyword>regeneration</keyword>
  <keyword>concentrated growth factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitogens</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

